Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1212, pseudogene (RNU6-1212P) is classified as a pseudogene related to the U6 small nuclear RNA (snRNA) gene family. The canonical U6 snRNA is a non-coding RNA component essential for spliceosome function and pre-mRNA splicing in eukaryotic nuclei[1][3]. However, RNU6-1212P is a pseudogenic copy—a genomic sequence similar to U6 snRNA genes that no longer produces functional RNA due to the accumulation of mutations[4]. Numerous U6 snRNA pseudogenes exist within vertebrate genomes, typically generated through retrotransposition and integration mechanisms[4]. Pseudogenes like RNU6-1212P do not encode protein, have no known biological function, and are not considered therapeutic targets[4]. There are no known drugs, mechanisms of action, biomarkers, or disease associations related to these pseudogenes. The entry may be flagged as incorrect for therapeutic databases, as RNU6-1212P is not an active gene, receptor, or pharmacological target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1212, pseudogene (RNU6-1212P).